110
Although the existing scientific data do not justify FDA regulatory
actions, FDA has urged the wireless phone industry to take a number
of steps, including the following:
•
Support needed research into possible biological effects of RF of the type
emitted by wireless phones;
•
Design wireless phones in a way that minimizes any RF exposure to the
user that is not necessary for device function; and
•
Cooperate in providing users of wireless phones with the best possible
information on possible effects of wireless phone use on human health.
FDA belongs to an interagency working group of the federal agencies
that have responsibility for different aspects of RF safety to ensure
coordinated efforts at the federal level. The following agencies belong
to this working group:
•
National Institute for Occupational Safety and Health
•
Environmental Protection Agency
•
Federal Communications Commission
•
Occupational Safety and Health Administration
•
National Telecommunications and Information Administration
The National Institutes of Health participates in some interagency
working group activities, as well.
FDA shares regulatory responsibilities for wireless phones with the
Federal Communications Commission (FCC). All phones that are sold
in the United States must comply with FCC safety guidelines that limit
r631.book Page 110 Tuesday, June 1, 2010 2:57 PM